IGC Pharma, Inc. (IGC) stock

IGCNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/3021% above fair value

$0.18−0.01 (-7.24%)

Close on Nov 12, 2026Market cap $19.07MP/E –Yield –

IGC Pharma statistics

75 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $19.07M; $280.48M
Enterprise Value: $18.79M; $148.62M
PS Ratio: 16.99; 3.60
PB Ratio: 2.93; 2.05
P/TBV Ratio: 25.06; 2.29

Enterprise valuationIndustry

EV / Sales: 16.73; 2.60

Share statisticsIndustry

Shares Outstanding: 103M; 58M
Shares Change (YoY): 20.8%; 10.9%
Float: 90M; 49M
Shares Held by Insiders: 13.2%; 12.1%
Shares Held by Institutions: 5.08%; 56.4%

Short sellingIndustry

Short Interest: 395,551; –
Short Interest Change: -37.8%; -0.76%
Short % of Float: 0.44%; 9.06%
Short % of Shares Outstanding: 0.38%; 6.30%
Days to Cover: 1.00; 5.13

Stock price statisticsIndustry

52-Week High: $0.39; –
52-Week Low: $0.08; –
20-Day Moving Average: $0.22; –
50-Day Moving Average: $0.25; –
200-Day Moving Average: $0.28; –
Average True Range (14): $0.02; –
Price Change (1 Week): -2.38%; 1.51%
Price Change (1 Month): -26.8%; -2.37%
Price Change (3 Months): -38.0%; -21.1%
Price Change (6 Months): -38.3%; -22.8%
Price Change (YTD): -34.4%; -22.6%
Price Change (1 Year): -52.3%; -21.0%
Price Change (3 Years): -39.9%; -24.8%
Price Change (5 Years): -87.5%; -76.9%
Price Change (10 Years): -49.4%; -63.2%
Average Volume (10 Days): 423,130; –
Average Volume (20 Days): 465,284; –
Average Volume (90 Days): 649,410; –
Relative Volume: 0.57; 0.80
Relative Strength Index (14): 31.4; 44.7
Volatility (1 Year): 53.6%; 80.2%
Beta (5 Years): 0.60; 1.07

MarginsIndustry

Gross Margin: 21.9%; 53.0%
Operating Margin: -986.8%; -38.5%
Pretax Margin: -702.1%; -11.8%
Profit Margin: -702.1%; -31.7%
EBITDA Margin: -986.8%; -27.7%

Returns on capitalIndustry

Return on Equity (ROE): -113.3%; -51.3%
Return on Assets (ROA): -81.1%; -40.7%
Return on Invested Capital (ROIC): -136.4%; -32.9%
Return on Capital Employed (ROCE): -167.2%; -38.1%

Financial positionIndustry

Current Ratio: 0.42; 3.31
Quick Ratio: 0.16; 2.41
Debt / Equity: 0.02; 0.50

GrowthIndustry

Revenue Growth (YoY): -15.4%; 7.26%

EfficiencyIndustry

Asset Turnover: 0.12; 0.40
Inventory Turnover: 1.37; 2.73
Revenue Per Employee: $16.76K; $429.38K
Profits Per Employee: -$117.69K; -$683.67K
Employee Count: 67; 75
WACC: 7.87%; 10.0%

Income statement (TTM)Industry

Revenue: $1.12M; $66.69M
Gross Profit: $246.00K; $116.10M
Operating Income: -$11.08M; -$20.99M
Pretax Income: -$7.89M; -$13.23M
Net Income: -$7.89M; -$21.61M
EBITDA: -$11.08M; -$16.85M
EPS (Diluted): -$0.08; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $413.00K; $67.18M
Total Debt: $128.00K; $116.91M
Net Cash (Debt): $285.00K; $16.98M
Net Cash Per Share: $0.00; $0.72
Equity (Book Value): $6.50M; $52.68M
Book Value Per Share: $0.06; $1.50
Tangible Book Value: $761.00K; $26.74M
Working Capital: -$1.79M; $78.52M

Dividends and yieldsIndustry

Earnings Yield: -41.3%; -21.0%

Taxes and interestIndustry

Income Tax: $0; $74.00K

Scores and fair valueIndustry

Altman Z-Score: -19.35; 0.26

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	IGC	S&P 500	Difference	IGC per year	S&P 500 per year
1 month	-33.2%	-2.7%	−30.5 pts
3 months	-35.5%	-1.7%	−33.7 pts
Year to date	-34.4%	+11.9%	−46.3 pts
1 year	-49.6%	+12.0%	−61.6 pts
3 years	-37.5%	+78.2%	−115.6 pts	-14.5%	+21.2%
5 years	-87.5%	+73.2%	−160.8 pts	-34.1%	+11.6%
10 years	-49.4%	+309.6%	−359.1 pts	-6.6%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M IGC shares were sold short on Oct 30, 2026, down 37.8% from the previous report, or 0.44% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 34.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	395,551	-37.8%	508,862	1.0
Oct 15, 2026	635,640	-31.8%	715,207	1.0
Sep 30, 2026	931,512	-13.2%	648,270	1.4
Sep 15, 2026	1,072,899	+48.0%	524,387	2.0
Aug 31, 2026	724,844	-5.6%	1,093,278	1.0
Aug 14, 2026	767,648	+41.7%	1,040,320	1.0
Jul 31, 2026	541,699	+39.2%	322,941	1.7
Jul 15, 2026	389,057	-19.8%	437,852	1.0
Jun 30, 2026	484,812	+133.0%	591,806	1.0
Jun 15, 2026	208,103	-82.3%	676,731	1.0
May 29, 2026	1,175,372	-9.3%	871,464	1.4
May 15, 2026	1,296,141	+11.7%	470,711	2.8